Bristol Myers Squibb Co. (BMY)
51.21
+0.56
(+1.11%)
USD |
NYSE |
Dec 10, 16:00
51.50
+0.29
(+0.57%)
Pre-Market: 06:00
Bristol Myers Squibb Profit Margin (Quarterly): 17.96% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Gilead Sciences, Inc. | 39.21% |
| Johnson & Johnson | 21.47% |
| Eli Lilly & Co. | 31.72% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 34.70% |
| Return on Assets | 6.43% |
| Return on Invested Capital | 8.82% |
| Gross Profit Margin (Quarterly) | 66.00% |
| Operating Margin (Quarterly) | 31.46% |
| Return on Net Operating Assets | 9.20% |